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ABSTRACT
THE ROLE OF MOLECULAR MOTORS IN PERIPHERAL NERVE REGENERATION
Melissa Ducommun Priest
Michael Granato
Following injury, axons of the peripheral nervous system have retained the capacity for
regeneration. While it is well established that injury signals require molecular motors for their
transport from the injury site to the nucleus, whether kinesin and dynein motors play additional
roles in peripheral nerve regeneration is not well understood. Here we use genetic mutants of
motor proteins in a zebrafish peripheral nerve regeneration model to visualize and define in vivo
roles for kinesin and dynein. We find that both kinesin-1 and dynein are required for zebrafish
peripheral nerve regeneration. While loss of kinesin-1 reduced the overall robustness of axonal
regrowth, loss of dynein dramatically impaired axonal regeneration and also reduced injuryinduced Schwann cell remodeling. Chimeras between wild type and dynein mutant embryos
demonstrate that dynein function in neurons is sufficient to promote axonal regrowth. Finally, by
simultaneously monitoring actin and microtubule dynamics in regenerating axons we find that
dynein appears dispensable to initiate axonal regrowth, but is critical to stabilize microtubules,
thereby sustaining axonal regeneration. These results reveal two previously unappreciated roles
for dynein during peripheral nerve regeneration, initiating injury induced Schwann cell remodeling
and stabilizing axonal microtubules to sustain axonal regrowth.
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CHAPTER 1: INTRODUCTION
Peripheral nerve regeneration: a clinical concern
Peripheral nerve degeneration results from injury or disease and is termed peripheral
neuropathy. In both of these instances, axons undergo a highly stereotyped
degeneration program known as Wallerian degeneration. The degeneration of peripheral
axons leads to sensory and/or motor loss as these neurons lose the connection to their
functional targets. Some peripheral neuropathies are inherited genetic conditions,
including the most common form called Charcot-Marie-Tooth disease (CMT), affecting 1
in 2,500 patients in the United States. Peripheral neuropathies can also be acquired,
including causes such chemotherapy treatments, diabetes, and peripheral nerve injuries.
While axons of the peripheral nervous system (PNS) have much greater capacity for
regrowth than those of the central nervous system (CNS), it is still estimated that fewer
than 10 percent of patients recover full function after peripheral nerve injury (1). There
are a number of challenges that peripheral nerves encounter during the process of
regeneration. First, the distances across which axons must regrow are typically quite
large in an adult human, and the speed at which peripheral axons regrow is not often
sufficient to reach the appropriate target organs. Additionally, this slow regrowth leaves
Schwann cells in the distal stump denervated for prolonged periods of time, and without
trophic signals from innervating axons this results in Schwann cell loss.
In addition to the rate of regrowth, the direction of regrowth is also a concern for
functional regeneration. During peripheral nerve regeneration, axons must navigate back
1

toward their original targets in an environment that is very different from that of the
developing embryo, when axons initially find their targets. The ease of pathfinding
depends on the nature of the injury–in crush injuries, the axons distal to the injury site
degenerate but the nerve tube stays in place, leaving an existing pathway for the
regrowing axons to follow back to their appropriate targets. In transection injuries, the
axons, Schwann cells, and basal lamina of the nerve tube are all disrupted and an
acellular transection gap must be traversed by axons in order for them to regrow in the
proper direction. This pathfinding task is much more complex, requiring more active
guidance of regrowing axons, and results in further reduced target innervation after this
type of injury. Further studies elucidating the cellular and molecular mechanisms that
promote axonal regrowth and guidance may reveal potential therapeutic targets for
human peripheral neuropathies.
While the field of peripheral nerve regeneration is far too large to be covered in single
section here, I have included a collection of reviews that discuss the current state of the
field (Table 1.1).
Neuron-intrinsic mechanisms of nerve regeneration
In recent years, several key neuron-intrinsic regulators of axonal regrowth have been
identified. Some of these signals are positive regulators, such as DLK, which has been
identified as critical in promoting axonal regrowth in both C. elegans motor neurons (2)
and the mouse sciatic nerve (3). In the central nervous system, several negative
regulators have been identified as intrinsic, inhibitory factors in axonal regrowth. Neuronspecific deletion of either PTEN or SOCS3 was found to improve axonal regrowth in the
2

optic nerve (4,5), and co-deletion of these two factors further increased axonal regrowth
after injury (6). These experiments demonstrate that intrinsic axonal regrowth potential
can be modulated by both activation of positive regulators, as well as downregulation of
pathways that inhibit axonal regrowth.
Neuron-extrinsic mechanisms of nerve regeneration
In addition to neuron intrinsic mechanisms, there are critical extrinsic mechanisms that
also promote nerve regeneration. The difference in regenerative capacity between axons
of the CNS and axons of the PNS was once largely attributed to the intrinsic growth
capacity of the neuron (7). Seminal experiments in which denervated peripheral nerve
stumps were grafted into an injured spinal cord revealed that axons of the CNS have the
capacity to regrow when surrounded by the environment of the PNS (7,8). This
demonstrated that a combination of inhibitory factors in the CNS environment and
growth promoting factors in the PNS environment contribute to the difference in
regeneration observed in CNS and PNS axons.
Many of the extrinsic factors involved in regeneration come from surrounding cell types
in the nerve. Schwann cells are the primary glia of the peripheral nervous system,
residing in close proximity to axons. The majority of Schwann cells associate with a
single axon, ensheathing the axon in tight wraps of myelin in a process known as
myelination (9). Schwann cells provide neighboring axons with trophic support important
for axonal maintenance and repair. Mice lacking Schwann cells exhibit early-onset
axonal neuropathy, indicating a requirement for Schwann cells in axonal maintenance
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(10). In addition to myelinating Schwann cells, there are also non-myelinating (Remak)
Schwann cells (11) and perineural ensheathing glia (12) in peripheral nerves.
In response to injury, both myelinating and non-myelinating Schwann cells in the distal
nerve stump dedifferentiate to a regeneration-promoting state and form bands of
Bungner (13,14). Schwann cells in the bands of Bungner proliferate and provide growthpromoting factors, such as NGF, BDNF, and FGF, to regrowing axons (15-17). As
regrowing axons enter the distal nerve stump, Schwann cells and their associated basal
lamina serve as a scaffold to guide axons toward their original targets (18). Once these
newly regrown axons arrive at their targets, Schwann cells stabilize and remyelinate
them (19). In addition to promoting growth in the peripheral nervous system, Schwann
cells transplanted into the central nervous system also promote axonal growth and
remyelination, suggesting that Schwann cells have therapeutic applicability (20-22).
Perineural glia have also recently been shown to play a role in nerve regeneration,
helping to engulf axonal debris and bridging the transection gap to promote axonal
regrowth (23).
In addition to non-neuronal cell types, extracellular molecules are other neuron-extrinsic
factors that help promote nerve regeneration. Our lab previously identified a pathway by
which glycosylated collagens help to specifically scaffold signaling molecules in order to
direct axonal regrowth in vivo (24). This highlights the value of studying nerve
regeneration in a system in which the behavior of both axons and Schwann cells can be
experimentally modified and visualized in a whole organism context, as such axonal
regrowth occurs through a fully in vivo environment.
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Microtubules and associated motors in nerve maintenance and regeneration
Mutations in microtubule associated proteins and motors have widely been identified as
causing neurodegenerative conditions, which highlights the importance of microtubules
and associated transport functions in neuronal health (Table 1.2). Microtubules are a
key component of the cytoskeleton, and these filaments consist of α-tubulin and ßtubulin heterodimers arranged in a 13-protofilament lattice. Axonal microtubules have
uniform polarity, with the minus ends toward the cell body and the plus ends toward the
synaptic terminals (25). As is the case in other cell types, microtubules in the neuron are
nucleated at the centrosome, from which they are transported in a dynein-dependent
manner into the axon (26-28). Microtubule organization is critical to axon formation and
stability–microtubules demonstrate increased stability in axons and it was also found that
microtubule stabilization is sufficient to induce axon formation (29).
Microtubules serve not only to provide structural support to the cell, but also as tracks for
active transport within the cell. Microtubule-associated motors move along microtubules
in a polarity-dependent manner. Kinesins are a large family of microtubule-associated
motors that move toward microtubule plus ends. Kinesin-1 is the conventional kinesin
and is composed of two light chains and two heavy chains – the heavy chains make up
the motor domain while the light chains are responsible for cargo binding and regulation
(30). Cargos of kinesin include organelles, proteins and RNAs (31). Kinesin-1 is critical
for neuronal maintenance, as mouse knockouts of various heavy chains cause neuronal
loss and dysfunction (32,33). Furthermore, human mutations in the kinesin-1 heavy
chain gene KIF5A have been found to cause a form of hereditary spastic paraplegia
(34,35), as well as Charcot-Marie-Tooth type 2 (36).
5

In addition to its role in neuronal homeostasis, kinesin-1 is also involved in axonal
outgrowth during both development and regeneration. During development, kinesin-1
binds and slides microtubules against one another, termed microtubule sliding (Figure
1.2). This activity had been found to drive major cell shape changes, and to specifically
drive both dendritic and axonal extension in neurons (37,38). After axonal injury, it was
found that kinesin-1-powered microtubule sliding is similarly required for axonal regrowth
(39).
The complementary motor to kinesin is dynein, a minus end-directed motor protein that
is responsible for all retrograde transport in neurons, carrying similar cargos such as
mitochondria, signaling endosomes, and autophagosomes. Dynein is a large protein
complex comprised of many subunits, with two homodimerizing heavy chains at the core
of the complex. The heavy chain contains the microtubule binding domains, ATPase
activity, as well as subunit interacting domains. The light and intermediate chains help
confer cargo specificity and stabilization to the dynein complex (40). Previously, three
mouse mutants with distinct dominant mutations in the singular dynein heavy chain,
dync1h1 (Loa, Cra and Swl), were identified in forward genetic screens as having
progressive motor or sensory neuron loss (41,42). Moreover, human patients with
heterozygous mutations in DYNC1H1 experience progressive motor neuron loss, with
multiple mutations now found to cause spinal muscular atrophy, lower extremity
dominant (SMA-LED) and Charcot-Marie-Tooth disease (CMT) (43,44). These findings
have underscored the importance of dynein-mediated transport in neuronal development
and maintenance. Dynein has also been found to organize the cytoskeleton during
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axonal outgrowth by transporting microtubules in a polarity-sorting manner to establish
uniform microtubule polarity in the axon (45).
In addition to its role in neuronal maintenance, dynein has also been found to have a
critical role in the neuron after injury. Following injury, one of the most important cellular
changes within the neuron is the cell body response. This response consists of structural
changes to organelles in the soma, as well as an increase in transcription and translation
(46,47). The cell body response is elicited by both negative and positive injury signals.
Negative injury signals result from a lack of target-derived trophic factors from the
disconnected, distal axon. For example, retrogradely transported NGF decreases 10-fold
after transection (48).
Conversely, positive injury signals are carried back to the cell body from the site of
injury. One such signal is the phosphorylation of MAP kinases, Erk1 and Erk2. These
activated MAPKs are carried retrogradely to the cell body linked to dynein through the
intermediate filament vimentin (49). Once in the cell body, injury signals up-regulate
regeneration associated genes, which promote axonal regrowth. These studies
demonstrate the importance of retrograde signaling within the neuron following nerve
injury.
While studies have previously demonstrated key roles for kinesin-1-powered microtubule
sliding and dynein-dependent injury signaling after axonal injury, both of these motors
bind many cargos and have multifaceted roles within the cell. This raises the possibility
that kinesin-1 and dynein may have additional functions after injury. Furthermore, the
studies of kinesin-1 and dynein function after axonal injury have lacked analysis of in
7

vivo dynamics in a multicellular environment, including the dynamics of regrowing axons
themselves and the role of surrounding Schwann cells as my work demonstrates.
Zebrafish as a model to study nerve regeneration in vivo
In order to dissect the cellular and molecular mechanisms of peripheral nerve
regeneration in vivo, we use the zebrafish larvae 5 days post-fertilization (dpf). At this
stage, the larvae are optically clear which allows for in vivo imaging of nerves in the
context of a live vertebrate animal. At 5 dpf, the nervous system is already fairly mature
– motor axons have fully extended, formed functional connections with their muscle
targets, and are myelinated by Schwann cells (50,51). Using combinations of transgenic
lines in conjunction with live cell imaging, we can monitor interactions between relevant
cell types, such as motor neurons and Schwann cells (Figure 1.3, 52). We use laser
mediated axotomy to fully transect motor nerves, which is followed by Wallerian
degeneration and functional regeneration, and combine this with the use of genetic
mutants to assess the requirements of a cell type or signaling pathway. Using this
approach, we previously described nerve-macrophage interactions in vivo, revealing a
novel nerve scanning behavior (51). We have also used this approach to provide the first
minute-by-minute account of interactions between motor axons and Schwann cells after
injury in vivo, which revealed a requirement for Schwann cells in guiding axonal regrowth
(52). Here, we use this system to assess the roles of the motor proteins kinesin-1 and
dynein in peripheral nerve regeneration in vivo and reveal novel roles for dynein in the
Schwann cell response to injury and microtubule modulation at the growth cone to
promote sustained axonal regrowth.

8

Table 1.1: Useful reviews of peripheral nerve regeneration
Review

Notes
Summary of clinical challenges

Mechanisms of Disease: what factors limit
the success of peripheral nerve
regeneration in humans? (53)

Retrograde signaling in axonal

Review of retrograde injury signaling

regeneration (54)

Intrinsic control of axon regeneration

Review of neuron-intrinsic mechanisms of
regrowth

(55)

The repair Schwann cell and its function

Review of Schwann function after injury

in regenerating nerves (56)

9

Table 1.2: Human disease-causing mutations in microtubule-associated proteins
Disease

Gene
MAPT (microtubule-

Reference

Alzheimer’s disease

(57-60)

SPAST/SPG4 (spastin,

Upper motor neuron

(61,62)

microtubule severing

diseases

associated protein tau)

protein)
DCTN1 (dynactin subunit

Perry syndrome; lower

1)

motor neuron disease

KIF5A (kinesin heavy

Hereditary spastic

chain isoform 5A)

paraplegia (SPG10)

KIF1Bß (mitochondrial

Charcot-Marie-Tooth

transport kinesin)

Disease

DYNC1H1 (cytoplasmic

Charcot-Marie-Tooth 2O;

dynein 1 heavy chain 1)

Spinal muscular atrophy
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(63,64)

(34,65)

(66)

(43,44)

Figure 1.1: Schematic of peripheral nerve injury and regeneration. (A) Anatomy of
an uninjured peripheral nerve. A long axon extends from the cell body of the neuron to
synapse with a target cell (target not shown). The axon is ensheathed in myelinating
Schwann cells. Red dashed line indicates site of transection. (B) Peripheral nerve after
injury and axon fragmentation. Distal section of the axon fragments and distal Schwann
cells dedifferentiate to a repair cell state. (C) Proximal axon section sprouts a growth
cone that navigates back towards the denervated distal nerve and original target.
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Figure 1.2: Schematic of microtubule sliding by motors kinesin-1 and dynein. (A)
Kinesin-1 slides microtubules with their minus ends out into the axon. (B) Dynein slides
microtubules with their plus ends out into the axon, and can also slide minus end out
microtubules back towards the cell body.
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Figure 1.3: Zebrafish as a model for peripheral nerve regeneration in vivo. Adapted
from Rosenberg et al., 2014 (A) 5 dpf zebrafish larvae with motor nerves labeled by
Tg(mnx1:GFP) (green). White box magnified in panels B-E. (B-E) Motor nerve, with
axons in green and Schwann cell membranes in magenta. Scale bar = 10 µm. Red box
indicates site of transection. Motor nerve uncut (B), 6 hours post-transection (C), 24
hours post-transection (D), and 48 hours post-transection (E).
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CHAPTER 2: KINESIN-1 AND DYNEIN IN NERVE REGENERATION
Axons of the mature peripheral nervous system have retained a remarkable ability for
regeneration. Although simple in concept, peripheral nerve regeneration is a complex
process that requires extrinsic as well as intrinsic mechanisms. Chief amongst the
intracellular mechanisms that contribute to axonal regeneration are microtubule
organization and dynamics as well as axonal transport. It has long been known that
following injury the pool of dynamic microtubules at the lesion site, as well as axonal
transport, increase (67-69). Given the central role of both microtubule dynamics and
axonal transport in promoting axonal regeneration, factors that regulate both processes
are prime candidates for regulating peripheral nerve regeneration.
The molecular motor proteins kinesin-1 and dynein are key regulators of both
microtubule organization and axonal transport, and have both been implicated in
peripheral nerve regeneration. Kinesin-1 is an anterograde motor that is essential for
maintaining neuronal homeostasis by transporting cargos, including organelles and
mRNA, from the cell body toward synaptic terminals. Kinesin-1 has also been shown to
drive axonal outgrowth during development and after injury (38,39). Dynein has similarly
been studied for its role in maintaining homeostasis by transporting cargo, however
dynein moves cargo retrogradely towards the cell body. Dynein also plays an important
role in axonal injury by trafficking injury signals, including components of JNK and ERK
MAPK pathways, which are generated at the lesion site and actively transported to the
cell body (70,71). There these injury signals initiate a regenerative response,
characterized first by upregulation of regeneration-associated genes that prevent
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neuronal cell death, and by initiating a genetic program that promotes regrowth of injured
axons back to their original targets (72,73).
More recently it has become clear that in addition to its role in retrograde transport,
dynein also functions in cytoskeletal organization and maintenance. For example, in C.
elegans dynein regulates local microtubule dynamics in dendrites to promote
microtubule stabilization (74). Additionally, in the axon dynein transports microtubules to
establish and maintain microtubule polarity (28,45,75). Finally, besides its preeminent
role in axonal homeostasis, dynein is also required for Schwann cell development and
myelination (76). Yet despite dynein’s well documented roles in both axons and glial
cells, the effects of dynein on the cellular behaviors of regenerating axons and their
associated glial cells in intact animals have not been examined.
In order to examine the diverse cellular functions of molecular motors in multiple cell
types, we combined genetic mutants with live imaging of nerve regeneration in larval
zebrafish, as previously described (51). This allowed us to study the real-time dynamics
of regenerating axons and surrounding Schwann cells in a whole organism context. We
find that the molecular motors kinesin-1 and dynein, albeit to different degrees, are both
required for axonal regrowth in vivo and that dynein is also required to initiate injuryinduced morphology changes in Schwann cells. We show that wild type neurons
transplanted into otherwise dynein mutant animals are able to regrow robustly, indicating
that neuronal dynein is sufficient to promote axonal regrowth. Finally, we find that dynein
is dispensable for initiation of axonal regrowth but is required to stabilize microtubules in
injured axons to generate persistent, long-range regrowth. These findings elucidate
15

previously unknown roles for dynein in the initiation of injury-induced Schwann cell
behaviors, and identify a distinct role for dynein in promoting axonal regeneration
through persistent axonal regrowth via microtubule stabilization.
Kinesin-1 and dynein are critical for peripheral nerve regeneration in vivo
To determine the in vivo roles of molecular motors in peripheral nerve regeneration, we
first assessed regeneration in mutants lacking kif5aa, which encodes the neuron-specific
Kif5A heavy chain of the conventional anterograde motor kinesin-1. We have previously
shown that laser mediated transection of motor nerves in larval zebrafish initiates a
Schwann cell dependent peripheral nerve regeneration program reminiscent of what is
observed in adult vertebrate (52). Following their complete transection at 5 days postfertilization (dpf), ventral motor nerves exhibit Schwann cell dependent functional
regeneration by 48 hours post- transection (hpt) (Figure 2.1, A-B, 52). Prior to
transection, kif5aa-/- motor nerves were indistinguishable from wild type nerves (Figure
2.1, C). By 48 hpt, motor axons in kif5aa-/- mutants had regrown across the full extent of
the ventral myotome, although when compared to wild type siblings the number of
fascicles that reached their ventral targets was reduced (Figure 2.1, D-E). Using a
previously established semi-quantitative scoring index (for details see materials and
methods and (52) we confirmed that compared to wild type siblings, motor axons in
kif5aa mutants exhibited reduced regeneration (p=0.0487, Fisher’s exact test).
We next assessed motor axon regeneration in genetic mutants for the dynein heavy
chain gene (dync1h1) which encodes a core component of the retrograde motor dynein.
These mutants survive through development due to maternally deposited dynein, which
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persists until 4 dpf (77). This allows the fish to develop normally but have minimal levels
of dynein at 5 dpf when we perform nerve transection assays. Importantly, this
dync1h1hi3684 allele is a presumed null, unlike human mutations in DYNC1H1 which have
been found to be dominant gain of function alleles (43,44).
Prior to injury at 5 dpf, dync1h1-/- motor axons exhibit normal architecture, presumably
due to the large maternal load sufficient to promote axonal development ((77), Figure
2.1, F). In contrast, following transection, motor axons in dync1h1-/- mutant animals
frequently failed to extend beyond the transection site (Figure 2.1, G; quantified in Figure
2.1, H). Analysis of dynein heterozygotes revealed a less severe defect in axonal
regrowth (p=0.0745), demonstrating a dose-dependent requirement for dynein in
promoting axonal regrowth. The severity of the regeneration phenotype we observed in
homozygous dync1h1-/- mutants was significantly stronger than that present in kif5aa-/mutants (p<0.0001 and p=0.0487, respectively). This is consistent with the notion that
other heavy chains of kinesin-1 as well as other kinesin family motors might compensate
for the absence of kif5aa (78). In contrast, dynein is the sole protein responsible for
microtubule-associated retrograde transport, and therefore the regeneration phenotype
we observe in homozygous mutants likely represents a complete block of retrograde
transport. We therefore focused on further defining the role of dynein in peripheral nerve
regeneration.
Dynein mutant motor neurons persist in 5 dpf larvae
After finding that dynein mutants have impaired axonal regrowth when injured at 5 dpf,
we next wondered whether this was truly a result of decreased regenerative capacity of
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the dynein mutant axons, or whether there was a reduction in the number of motor
neurons in a 5 dpf mutant larvae that caused fewer motor axons to regrow. It is possible
that the lack of dynein in motor neurons is lethal to the cells, so we performed TUNEL
staining in uninjured larvae at 5 dpf to determine whether there was increased cell death
of motor neurons in the dynein mutants (Figure 2.2, A). In the wild type siblings, very few
TUNEL positive cells were observed across the spinal cord, and no TUNEL positive cells
were labeled in the ventral spinal cord where the motor neurons reside (Figure 2.2, B). In
dynein mutant larvae, an increased number of TUNEL positive cells were observed in
the spinal cord, indicating that there is some general increase in cell death in the
mutants. To determine whether any of this cell death was in motor neurons, we
quantified the number of TUNEL positive cells in the ventral spinal cord and found that
this number was minimal (4 TUNEL+ cells across 36 hemisegments). Additionally, none
of the TUNEL+ cells colocalized with the motor neuron label (tg(mnx1:GFP)), so we
concluded that while the dynein mutants exhibited an increase in cell death at 5 dpf, this
does not affect the motor neuron population (quantified in Figure 2.2, D). This indicates
that rather than a lack of viable motor neurons to regrow axons, motor neurons persist in
dynein mutant larvae at 5 dpf and the decreased regeneration observed in dynein
mutants is in fact a defect specific to the process of axonal regrowth.
Dynein is required for injury-induced Schwann cell remodeling
In addition to its well-studied function in neurons, dynein is also required for proper
differentiation and myelination of Schwann cells during development (14). Furthermore,
in zebrafish lacking Schwann cells, regenerating axons sprout from the proximal nerve
stump but fail to grow across the injury gap (20), somewhat reminiscent of the
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phenotype we observe in dynein mutants. Given the importance of Schwann cells for
peripheral nerve regeneration and the role of dynein in Schwann cell development, we
sought to determine whether dynein is also required for the Schwann cell response to
injury, characterized by stereotyped changes in Schwann cell morphology.
We have previously shown that before injury, Schwann cell membranes ensheathe
individual motor axons, and that following post-injury axonal fragmentation, Schwann cell
membranes reorganize, changing from a smooth, tube-like appearance to a more
rounded and granular morphology (20), indicative of their transition to an activated,
dedifferentiated state—known as the repair cell state—that promotes axonal
regeneration. Previous studies revealed that in dynein mutants, Schwann cells
development prematurely arrests at the promyelinating stage (14). We therefore first
wanted to determine whether immature Schwann cells are able to respond appropriately
to injury. For this we examined a mutant for the G-protein coupled receptor GPR126, in
which Schwann cells also arrest at the promyelinating stage (21), similar to what has
been reported for dync1h1 mutants. Analysis of gpr126 mutants revealed that Schwann
cells respond to injury by extending their membranes dramatically compared to their preinjury state, indistinguishable from wild type Schwann cells (Figure 2.3, A-D). This
demonstrates that developmentally arrested Schwann cells are still able to respond
appropriately to nerve injury.
Having determined that promyelinating Schwann cells are competent to respond
appropriately to nerve injury, we next examined the behavior of dync1h1-/- mutant
Schwann cells. Unlike wild type and gpr126 mutant Schwann cells, we find that following
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nerve transection dync1h1-/- mutant Schwann cells fail to initiate any morphological
changes, and instead retain their pre-injury morphology and membrane position for the
duration of the imaging period (up to five hours), arguing against a delay in onset but
rather for a complete lack to initiate a Schwann cell injury response (Figure 2.3, E-F). To
quantify this phenotype, we measured the changes in Schwann cell width following
nerve transection as a simpler proxy for the complex changes in Schwann cell
morphology (Figure 2.3, G). This revealed that while wild type and gpr126-/- Schwann
cells significantly increase in width after injury, dync1h1-/- Schwann cells show no
significant change. Thus, while dync1h1-/- mutant axons initiate fragmentation following
injury, their associated Schwann cells fail to respond, consistent with the idea that
dynein is critical for injury-induced Schwann cell remodeling.
Neuronal dynein is sufficient to promote axonal regrowth
Our results reveal injury-induced phenotypes in two cell types after injury in dynein
mutants, and we therefore wondered whether dynein functions in neurons or Schwann
cells to promote axonal regrowth. To determine the cell type in which dynein functions to
promote axonal regrowth, we generated blastula stage chimeras (27) that contained wild
type motor neurons and axons in otherwise dync1h1-/- larvae (Figure 2.4, A-B). Control
transplantations have previously shown that wild type cells transplanted into wild type
embryos generate motor neurons that are morphologically and functionally unaffected by
transplantation (22). Following development and subsequent transection in a dync1h1-/environment, wild type axons were able to regenerate robustly for the first 9 hours after
sprouting (Figure 2.4, C-F), in a manner indistinguishable from wild type axons in a fully
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wild type environment. This indicates that restoring dynein specifically in neurons in a
dynein mutant is sufficient to promote axonal regrowth, demonstrating a neuron-intrinsic
role for dynein during peripheral nerve regeneration. While technical considerations
prevented us from visualizing Schwann cells in chimeric nerves, it is unlikely that wild
type axonal regrowth would rescue dynein mutant Schwann cell response to injury, as
these processes are temporally distinct—Schwann cells respond to injury between 2 and
4 hours post transection, while axons do not begin to regrow until about 9 hours after
transection.
Interestingly, we found that dync1h1-/- axons that had wild type axons in the same nerve
regrew more robustly than dync1h1-/- axons in nerves with no transplanted cells (14.23
± 2.06 μm growth in dync1h1-/- larvae without transplants, see below; 39.33 ± 4.72 μm
growth in dync1h1-/- larvae with transplants; Figure 2.4, F). In several instances, we
observed dync1h1-/- axons growing along previously extended wild type axons (Figure
2.4, G-I). This indicates that the presence of wild type axonal regrowth is able to partially
rescue the dync1h1-/- axonal regrowth defects. Thus, while dynein acts intrinsically in
neurons to promote axonal regrowth, it may also play a role in inter-neuronal interactions
during regeneration.
Dynein stabilizes axonal growth during regeneration
We next asked how dynein promotes axonal regeneration within peripheral nerves.
Peripheral nerve regeneration is a dynamic process composed of several defined
stages, starting with growth cones emerging from the proximal stump and probing the
injury gap environment. This is followed by stabilization of axonal regrowth across the
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injury gap and along the correct trajectory, and finally rapid, sustained axonal regrowth
towards their original targets (23). We used live cell imaging after nerve transection to
quantify axonal dynamics in dynein mutants and determine which of these stages
require dynein. In wild type siblings, we observed growth cones emerging from the
proximal stump extending (3.54 events per 8 hours) and retracting (1.08 events per 8
hours) repeatedly, consistent with the idea that these growth cones are probing the
injury gap for a path towards their original targets (Figure 2.5, A-B). We found that
dync1h1-/- axons exhibit similar frequencies of axonal extensions and retractions (Figure
2.5, C-D), suggesting that they probe the injury gap as actively as their wild type siblings
(Figure 2.5, E).
We next examined the second stage of axonal regeneration when axons become
stabilized and then extend toward their original targets. To quantify this process, we
measured the overall displacement of regenerating growth cones over the first ~8 hours
after sprouting began. We found that the majority of regenerating wild type axons grew
beyond the transection site within 8 hours of sprouting (Figure 2.5, F), travelling an
average of 41.49 μm (SEM ± 5.84) over this time period. In contrast, regenerating
dync1h1-/- axons rarely extended beyond the transection site (Figure 2.5, G), travelling
an average of 14.23 μm (SEM ± 2.06) and never exceeding 21.94 μm in growth.
Moreover, quantification of growth cone displacement at 8 hours post transection
revealed that compared to regenerating wild type axons, dync1h1-/- axons exhibited a
significant decrease in axonal extension (Figure 2.5, H). Combined these results argue
that rather than initiating growth cone sprouting and short range axonal extensions,
dynein predominantly acts early during axonal regeneration to stabilize regenerating
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axons thereby promoting persistent, long-range regrowth.
Dynein stabilizes microtubules to promote persistent regrowth
Dynein has recently been shown to play a critical role in generating and maintaining
microtubule organization, both processes central to axonal growth (10,11,24,25). To
determine whether dynein regulates microtubule dynamics in axons during regeneration,
we used a transgenic line that simultaneously labels actin and microtubules in motor
neurons (mnx1:Gal4; UAS:lifeact-GFP-v2a-EB3-RFP). Growth cone extension occurs in
three stages: first, protrusion driven by F-actin, then engorgement driven by microtubulebased transport of organelles and vesicles, and finally consolidation in which the growth
cone contracts and stabilizes to form a cylindrical axon shaft (26). In regenerating wild
type axons, filopodia extend at the growth cone and microtubules follow behind,
stabilizing and consolidating newly formed protrusions (Figure 2.6, A- D). The majority of
regenerating dync1h1-/- axons (n=30/37) displayed one of two phenotypes characteristic
for microtubule disruption. In 59 percent (n=22/37) we observed filopodia extension
followed briefly by microtubule extension (Figure 2.6, E-F) and then arrest at the
engorgement stage before finally retracting (Figure 2.6, G-H). In 22 percent (n=8/37) of
regenerating dync1h1-/- axons, microtubules faithfully followed filopodia extending at
growth cones. However, rather than consolidating in the proximal growth cone, they
adopted a looped conformation at the leading edge of the growth cone, leading to
stalling and retraction (Figure 2.6, I-M). This demonstrates that lack of dynein leads to
loss of microtubule organization at regenerating growth cones and stalling of
regenerating axons early during the regeneration process. Combined, these findings
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support a model by which dynein plays a critical role in regulating microtubule dynamics,
thereby stabilizing growth of regenerating axons as they initiate their trajectory across
the injury gap and towards their original targets. Our data reveal a critical role for dynein
in promoting axonal extension via microtubule stabilization, as well as a previously
uncharacterized role in initiating Schwann cell response to injury.
Dynein is required for cytoskeletal maintenance in axons
Given that dynein regulates microtubule dynamics in the axon during regeneration, we
wondered if dynein was also required for long term maintenance of the axonal
cytoskeleton. While the homozygous dync1h1 mutants are only viable until 8 dpf, the
heterozygotes are fully viable into adulthood. This gave us the opportunity to examine
axons in animals with a reduction in functional dynein levels and determine how this
effects the cytoskeleton long-term.
In collaboration with Clara Franzini-Armstrong, we fixed dync1h1 heterozygotes at 2
months of age (wild type n=2 fish, dync1h1+/- n=2 fish) and performed electron
microscopy on cross sections of ventral motor nerves. Dissections, fixation and
sectioning were all performed in parallel across samples. In the wild type siblings, we
found nicely organized cytoskeletal components within most axons. Elongated
intermediate filaments were highly ordered and microtubules were apparent in the
majority of axon sections. In the dync1h1 heterozygotes, most axons contained
disordered intermediate filaments and many sections lacked apparent microtubules
(Figure 2.7, quantified in Figure 2.8). This suggests that dynein is required to maintain
cytoskeletal structure in motor axons.
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There are several key experiments that should follow up on these preliminary findings –
first, the initial experiment should be repeated to confirm that the disrupted cytoskeleton
in dync1h1 heterozygotes is not simply an artifact from fixation and sectioning. While this
is unlikely due to the number of samples in the first experiment, it would also be an
extremely surprising finding that adult axons can function with a severely disrupted
cytoskeleton. Mutations in various cytoskeletal proteins have been found to cause
severe neurodegeneration in humans, indicating that cytoskeletal structure is critical to
neuronal maintenance and function (79).
Another critical question regarding the cytoskeletal defects observed in dync1h1
heterozygote adults is whether the cytoskeletal structure degenerates over time, or
whether it is improperly established during development. To distinguish between these
possibilities, electron microscopy should be performed on dync1h1 heterozygote larvae
at between 3-5 dpf, after the axonal cytoskeleton is established but likely before any
cytoskeletal degeneration could occur. If the axonal cytoskeleton is intact and properly
organized in the heterozygous larvae, this would suggest that the cytoskeleton develops
properly despite reduced dynein levels but subsequently degenerates over time,
indicating that dynein is required for cytoskeletal maintenance. If the axonal cytoskeleton
is already disordered in the heterozygote larvae, this would indicate that dynein is
required to establish the cytoskeleton rather than to maintain it.
Dynein promotes axonal degeneration after injury
Wallerian degeneration is both a highly stereotyped and highly conserved process,
occurring in organisms from insects to mammals. Axonal degeneration is initially marked
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by membrane beading and swelling, followed by rapid breakdown of the cytoskeleton.
After the axon fragments, surrounding cells, such as Schwann cells and macrophages in
the peripheral nervous system, engulf and digest cellular debris. While debris clearance
is dependent on surrounding cell types, axon fragmentation is a neuron-intrinsic event
(80). It was originally thought that the loss of trophic support following injury caused
axonal degeneration. However, expression of a novel fusion protein in a spontaneous
mouse mutant, WldS, was found to protect injured axons from degeneration (81). This
suggests that axonal death is an active process, rather than a passive, wasting process
resulting from loss of trophic factors. Furthermore, a more recent study found that a loss
of function mutation in the protein dSarm results in delayed axonal degeneration. This
finding demonstrates that there are specific pro-death signals involved in axonal
degeneration (82). However, axonal death is distinct from apoptotic death as it is
caspase-independent and localized to the axon, leaving the soma intact (83).
The cytoskeletal events that occur during axonal degeneration have been well
characterized. Cytoskeletal breakdown is initiated by both the ubiquitin-proteasome
system (UPS) and calpain-mediated proteolysis (84,85). These processes are calciumdependent and therefore upregulated after injury due to an initial increase in intracellular
calcium levels. Inhibiting UPS and calpain either directly or through calcium chelation
delays cytoskeletal breakdown, although it does not prevent initial beading and swelling
of the axonal membrane (83,84,86). This indicates that there must be additional
mechanisms of cellular breakdown involved in initiating axon fragmentation that are still
unknown.
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To determine whether the motor protein dynein is involved in the process of axonal
degeneration, we transected nerves in 5 dpf dynein mutant larvae and performed
timelapse imaging of the distal nerve stump beginning shortly after injury. We found that
compared to their wild type siblings, dynein mutant larvae exhibited a dramatic increase
in the time to first axonal fragmentation (Figure 2.9). Given that the time to axonal
fragmentation increases in the absence of dynein, this demonstrates that dynein
promotes axonal degeneration in vivo. There are several possibilities of how dynein may
promote axonal degeneration. Interestingly, when axonal fragmentation begins, the
entire length of the axon fragments simultaneously (87), suggesting spatial and temporal
coordination of the fragmentation process. As dynein carries signaling endosomes
throughout the axon, it is possible that some of these active death signals required for
Wallerian degeneration may be transported by dynein to properly localize throughout the
axon after injury and coordinate the initiation of fragmentation.
Alternatively, it is possible that dynein coordinates some of the mechanical breakdown
required for the process of fragmentation and degeneration. Dynein is required for
axonal autophagy as it transports autophagosomes, which are intracellular vesicles that
form a double membrane that engulfs cytoplasmic contents and delivers them to
lysosomes for degradation. In neurons, autophagosomes initially form and sequester
cytoplasmic contents at the distal end of the axon and move retrogradely as they mature
and ultimately fuse with lysosomes, which are then termed autolysosomes (88).
Retrograde transport by dynein is critical in mediating encounters between
autophagosomes and lysosomes to allow for fusion and acidification of autolysosomes
(89). Though there is evidence for increased autophagy in degenerating neurons
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(90,91), the transport and function of autophagosomes during axonal degeneration
remains unclear. Given that dynein mutants exhibit delayed degeneration after injury and
autophagosomes are a direct cargo for dynein, future experiments should examine
autophagy in dynein mutant axons to determine whether dynein-dependent transport of
autophagosomes contributes to axonal degeneration in vivo.
Taken together, the studies in this chapter reveal for the first time an in vivo requirement
for the motor proteins kinesin-1 and dynein in nerve regeneration. We also identified
novel roles for dynein in the process of nerve regeneration, including involvement in
axonal extension via modulation of microtubule dynamics and initiation of Schwann cell
morphology changes after injury. Preliminary studies suggest involvement of dynein in
cytoskeletal maintenance of axons as well as an active role in the initiation of axonal
fragmentation after injury. Here we have identified that in vivo, dynein promotes axonal
degeneration, regrowth, and maintenance.
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Figure 2.1: Dynein and Kinesin-1 are required for peripheral nerve regeneration in
vivo. (A) Wild type motor nerve pre-lesion (red box, transection site; scale bar = 20 µm).
(B) By 48 hpt, several fascicles have regrown fully across the ventral myotome (green
arrowheads, regrown axons, strong regeneration). (C) kif5aa-/- motor nerve pre-lesion.
(D) At 48 hpt, some axons have extended across the myotome (blue arrowheads,
regrown axons, moderate regeneration). (E) Quantification of kif5aa mutant regeneration
at 48 hpt (wild type siblings, n=66 nerves; kif5aa-/-, n=20 nerves, p=0.0487, Fisher’s
exact test).
(F) dync1h1-/- motor nerve pre-lesion. (G) By 48 hpt, regrowing axons have extended
slightly but failed to reach the ventral extend of the myotome (red arrowheads, stalled
axons, no/weak regeneration). (H) Quantification of dync1h1 mutant regeneration at 48
hpt (dync1h1+/+, n=59 nerves; dync1h1+/-, n=21 nerves; dync1h1-/-, n=25 nerves;
p=0.007; p=0.0006; p<0.0001, respectively, Fisher’s exact test).
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Figure 2.2: Dynein mutant motor neurons persist in 5 dpf larvae. (A) Schematic of 5
dpf larvae. Motor neuron cell bodies shown in green, red box indicates area imaged for
TUNEL quantification. (B-C) TUNEL staining of spinal cord of uninjured larvae at 5 dpf.
Motor neuron cell bodies labeled in green (mnx1:GFP), TUNEL + cells labeled in red. (B)
Wild type larvae and (C) dync1h1-/- larvae. (D) Quantification of TUNEL + cells in the full
spinal cord and ventral spinal cord across 36 hemisegments (n= 3 larvae).
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Figure 2.3: Dynein is required for injury-induced Schwann cell morphology
changes. (A-F) Schwann cells in 5 dpf larvae labeled by Tg(sox10:mRFP). (A) Prior to
injury, wild type Schwann cells have smooth, straight membranes that are tightly
associated with the axonal track (scale bar = 5 µm). (B) After axonal fragmentation,
Schwann cell membranes change morphology and widen to accommodate axonal
debris. (C) Prior to injury, gpr126-/- Schwann cells are loosely associated with axons as
they do not myelinate. (D) After axonal fragmentation, gpr126-/- Schwann cells are able
to change morphology and widen. (E) Prior to injury, dync1h1-/- Schwann cells are
loosely associated with axons as they also do not myelinate. (F) After axonal
fragmentation, dync1h1-/- Schwann cell membranes maintain an elongated
conformation and do not dramatically change morphology, indicating a disrupted injury
response. (G) Quantification of Schwann cell width pre- and post-fragmentation in
gpr126 and dync1h1 mutants.
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Figure 2.4: Neuronal dynein is sufficient to promote axonal regrowth. (A) ~10
rhodamine-labeled cells were transplanted from wild type blastulas to dync1h1-/blastulas. (B) At 5 dpf, nerves contained wild type neurons (transplanted cells labeled by
rhodamine-dextran, magenta) in a dync1h1-/- larva (host motor neurons labeled by
Tg(mnx1:GFP), green; scale bar = 10 µm). (C-E) After transection, wild type axons
(magenta arrowheads) are able to regrow robustly in the dync1h1-/- embryo, while
dync1h1-/- host axons regrow significantly less (green arrowheads; scale bar = 10 µm).
(F) Quantification of growth cone displacement in dync1h1-/- host axons and
transplanted wild type axons. Open circles indicate dync1h1-/- mutant axons that grew
along transplanted wild type axons. (G-I) Some dync1h1-/- axons demonstrated
improved regeneration in the presence of wild type axons in the same nerve. Here, a
dync1h1-/- axon (green arrowheads) follows along a previously regrown wild type axon
(magenta arrowheads; scale bar = 5 µm).
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Figure 2.5: Dynein stabilizes axonal extensions during regeneration. (A-B) In wild
type animals, regenerating axons begin probing the environment by extending and
retracting (green and red arrowheads, respectively; scale bar = 5 µm). (C-D) dync1h1-/axons also extend and retract after injury. (E) Quantification of extension and retraction
events in wild type siblings (n=13 axons) and dync1h1-/- axons (n=13 axons). (F-G)
Measurement of overall growth cone displacement from transection site ~16 hpt in wild
type siblings (F; blue arrowheads, growth cones; scale bar = 10 µm) and dync1h1-/- (G;
red arrowheads, growth cones). (H) Quantification of growth cone displacement ~16 hpt
(wild type siblings, n=15; dync1h1-/-, n=10; p=0.0005, unpaired t-test).
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Figure 2.6: Dynein stabilizes microtubules to promote persistent regrowth. (A-D)
Regenerating wild type axons first extend actin protrusions then extended microtubules,
leading to stable growth (scale bar=5 µm; green arrowheads, actin; magenta
arrowheads, microtubules). (E-H) dync1h1-/- axons extend actin protrusions followed by
microtubule growth that arrests during growth cone engorgement and leads to axon
retraction (G,H). (I-L) dync1h1-/- axons extend actin protrusions but microtubules form
aberrant loop structures (magenta arrowheads), leading to axonal retraction. (M)
Quantification of microtubule organization in regrowing axons of dync1h1 mutants
(siblings, n=19 axons; dync1h1-/-, n=37 axons; p<0.0001, Fisher’s exact test).
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Figure 2.7: Dynein maintains cytoskeletal structure in motor axons of adult
zebrafish. (A-D) Cytoskeletal structure of large caliber axon (red outline), scale bar =
500 nm. Wild type sibling (A,C) and dync1h1+/- (B,D). Red arrows, microtubules; blue
arrows, intermediate filaments.
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Figure 2.8: Quantification of cytoskeletal structure in motor axons of adult
dync1h1+/- zebrafish. (A) Quantification of intermediate filament organization in wild
type (n=43 axons) and dync1h1+/- (n=33 axons) motor axons. (B) Quantification of
microtubules present in wild type (n=43 axons) and dync1h1+/- (n=33 axons) axons.
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Figure 2.9: Dynein promotes axonal degeneration after injury. Time to first axonal
fragmentation after injury in wild type and dync1h1-/- mutant axons.
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CHAPTER 3: NOVEL IN VIVO IMAGING APPROACHES
In vivo imaging of cytoskeletal dynamics in Schwann cells
Schwann cells are critical in promoting axonal regrowth and nerve regeneration.
Following nerve injury, Schwann cells distal to the lesion site respond dynamically by
breaking down their myelin and dramatically altering their morphology. These
morphological changes are accompanied by changes in transcriptional profile –
Schwann cells dedifferentiate to a state similar to the immature Schwann cell, termed
the repair cell, during regeneration. In this pro-regenerative state, Schwann cells can
engulf axonal debris, migrate, proliferate, and ultimately remyelinate regrown axons.
Previous work from our lab found that Schwann cells are required for proper axonal
regrowth in vivo (92). Furthermore, studies transplanting denervated Schwann cells from
peripheral nerves into CNS injury sites found that Schwann cells are able to promote
axonal regrowth of CNS axons (7). Despite their therapeutic potential, many questions
remain regarding the morphological and molecular changes in Schwann cells that
promote neural repair. Though factors have been identified that initiate Schwann cell
dedifferentiation after injury (93-95), a comprehensive description of the changes in
Schwann cell morphology and cytoskeletal organization in vivo is missing, mainly due to
the technical challenges of imaging regeneration in live intact animals. Similarly, if and to
what extent changes in the Schwann cell cytoskeleton are critical for axonal
regeneration is currently unknown.
Current understanding of the Schwann cell cytoskeleton comes predominantly from
immunohistochemistry in cultured Schwann cells (96-99). While this has provided some
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structural information, static images lack dynamic information and indication of
microtubule polarity. Furthermore, the morphology of Schwann cells in culture can vary
widely, and these Schwann cells lack association with axons which is a primary
determinant of morphology in vivo.
In order to visualize the Schwann cell cytoskeleton in vivo, I specifically examined
microtubules which are critical in directing and maintaining cell shape. I expressed
fluorescently labeled EB3, a microtubule plus-end binding protein which marks the
growing ends of microtubules, in Schwann cells. This allowed me to observe microtubule
dynamics in Schwann cells live, in real time and importantly also relative to their
associated axons, which are critical to the complex, three-dimensional morphology of
Schwann cells in vivo. The in vivo Schwann cell cytoskeleton has not previously been
described, even in cells before injury, due to the technical challenges of visualizing such
components in a live animal. I similarly encountered many technical challenges in this
pursuit, the details of which I will report here.
The major challenge in visualizing microtubules in Schwann cells of zebrafish larvae was
expressing this marker in Schwann cells at all. Initially, I tried to use the sox10(7.2kb)
promoter to drive expression of EB3 in Schwann cells transiently so that I could observe
individual Schwann cells using the mosaic labeling that results from transient
expression. When injecting the construct (sox10(7.2kb):EB3-GFP) and looking for
transient expression, I frequently saw expression in other cell types labelled by sox10,
as this is a broad marker of neural crest lineage. Across the thousands of fish I have
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examined for transient Schwann cell expression using the sox10(7.2kb) promoter, I still
to this day have never seen a Schwann cell labeled transiently.
My next approach was to generate stable transgenic lines using the sox10(7.2kb)
promoter, as this promoter has previously been used to successfully generate lines
labeling Schwann cells in zebrafish (100). I injected the sox10(7.2kb):EB3-GFP
construct and raised ~100 embryos to adulthood. I then screened for lines that labeled
microtubules in Schwann cells and identified two separate lines. The first, line 4, labeled
microtubules at a high enough expression level to easily see comets but not so high as
to fill the cell with free EB3 (Figure 3.1A). Unfortunately, when I tried to raise this
identified larvae (and several of its siblings with similar expression patterns) to adulthood
to maintain the line, they all died. It is possible that even with levels of EB3 that were
ideal for visualizing microtubules, this still may have negatively impacted microtubule
dynamics in the neural crest cells of these individuals, causing lethality.
The second line, line 8, had a slightly lower level of EB3 expression, although comets
could still be easily visualized before injury (Figure 3.1B). An important point here for the
purpose of visualizing microtubules after injury is that we use a laser commonly used for
FRAP analysis to perform our nerve transections. This laser causes photobleaching of
GFP, which with cytosolic GFP can recover over time as more GFP diffuses from parts
of the axon that were not cut. It seems, however, that the photobleaching of EB3-GFP
was much more severe and long-lasting, preventing the visualization of microtubules in
Schwann cells for a few hours after injury, exactly when the critical morphological
changes are occurring in Schwann cells.
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I was able to successfully raise two identified line 8 larvae to adulthood, and outcrossed
them to a wildtype stain to maintain the line. Unfortunately, when these adults were then
incrossed, the level of labeled EB3 in Schwann cells was too low to image and quantify.
This raises another important point about generating transgenic lines in zebrafish: using
the Tol2 transposase greatly increases the rate of transgenesis, however it does not
always generate the most reliable stable lines. With Tol2 transgenesis, concatamers of
the transgene can be formed, meaning that multiple copies of the desired gene may
integrate into the genome. While this can be helpful for expression levels initially, this
also means that with subsequent outcrossing, some of these copies are lost, and
expression level can decrease.
Given the difficulty of identifying stable transgenic lines with an EB3 expression level
suitable for imaging before and after injury, I turned to another Schwann cell promoter,
Claudin K. Claudin K is a myelin-associated protein and thus labels only myelinating
Schwann cells and oligodendrocytes. Using the CldnK promoter, I was able to see good
transient expression of EB3 in Schwann cells (Figure 3.1C). The expression pattern
tends to be clonal for a single nerve, so if one Schwann cell was labeled in a nerve, it
also usually labeled all of the Schwann cells in that nerve. I also compared this structure
to acetylated tubulin staining in 5 dpf fixes larvae (Figure 3.1D) and found the live
images to provide a more defined structure.
While CldnK was a much more reliable promoter and allowed me to successfully
express many proteins both transiently and in stable transgenic lines, the most ideal
levels of EB3 for live imaging in Schwann cells came from expression using stable lines
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generated with the Gal4/UAS system. I crossed a sox10:Gal4 stable line and with a
UAS:EB3-GFP line and this yielded bright labeling in most Schwann cells (Figure 3.1E).
Interestingly, levels of EB3-GFP occasionally varied greatly between Schwann cells of
the same nerve, allowing for some single cell resolution. The levels of EB3-GFP were
strong enough to prevent photobleaching after laser transection, which allowed me to
image cytoskeletal dynamics after injury (Figure 3.1F).
Going forward, these lines can be used to visualize dynamics of the Schwann cell
cytoskeleton first in wild type larvae, both before and after nerve injury. This will
determine how the cytoskeleton changes after injury, as Schwann cells transition from
their mature, myelinating state into a repair cell state. The lines have also already been
crossed into a dynein mutant background which will allow us to assess if and how the
Schwann cell cytoskeleton differs in dynein mutant nerves, both before and after injury.
One unique challenge for assessing the Schwann cell cytoskeleton in vivo is the
complex cellular morphology. This dramatically increases the complexity of automatically
tracking and measuring individual EB3 comets, as many more comets are present
simultaneously than in a single section of an axon. I have previously used the Imaris
software to automate the tracking of EB3 particles, and have had moderate success with
the automatic “track particles” feature. It is likely that a more specific protocol will be
needed to accurately track and measure the microtubule dynamics in Schwann cells.
This preliminary data represents the first visualization of the Schwann cell cytoskeleton
in a live, whole organism context.
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In vivo imaging of nerve regeneration in midlarval zebrafish
The early larval zebrafish is an excellent system for studying nerve regeneration, as the
larvae are optically clear at 5 dpf, allowing for in vivo imaging of cellular interactions after
injury. Motor nerves in 5 dpf larvae demonstrate stable branching patterns and a degree
of myelination roughly equal to that of a one week postnatal mouse (87,101,102). While
this stage of larval development has many of the hallmarks of a mature motor nerve, it
would also be useful to assess nerve regeneration in an even more mature animal. In
our current experimental paradigm, nerves are transected in 5 dpf larvae and
regeneration is assessed 48 hours later, when the larvae are 7 dpf. The ability to image
older larvae would also allow us to assess nerve regeneration beyond 48 hours after
transection. This would be useful for examining aspects of nerve regeneration that take
longer than 48 hours, such as Schwann cell remyelination.
As larvae mature from the early to the mid-larval stages, this is accompanied by
substantial growth in terms of both length and thickness. At 5 dpf, the average length of
a larva is 4 mm and by 15 dpf, the length increases to an average of 15 mm. This
predominantly affects the number of fish that can be imaged simultaneously in a single
imaging dish (Figure 3.2A). The greater consideration for imaging, however, is the
thickness of the fish. As the fish grows, there is more tissue between the microscope
objective and the spinal motor nerves, making it more difficult to image clearly. The
larvae also have a more fully inflated swim bladder in the midlarval stages, making the
trunk section substantially thicker than the tail section.
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To determine how late the spinal motor nerves of midlarval zebrafish can be imaged
using standard spinning disk confocal live imaging techniques, I raised larvae expressing
mnx1:GFP to 21 dpf and imaged periodically from 5 dpf forward. I imaged motor nerves
in both the midtrunk section (Figure 3.2B, box 1) as well as the tail (Figure 3.2B, box 2). I
also transected these nerves at each timepoint to see in the laser could penetrate the
tissue sufficiently in each location.
At all timepoints (14, 16 and 19 dpf) nerves were successfully imaged and transected in
both the midtrunk section as well as the tail (Figures 3.3, 3.4, 3.5). One challenge of
nerve regeneration as an animal grows is that the distance across which an axon must
regrow becomes much larger. The motor nerves of the trunk in the midlarval stages are
much greater in length while the motor nerves of the tail are much shorter, and therefore
a less useful tool to study more mature nerve regeneration. Surprisingly nerves in the
midtrunk could be successfully imaged out to 19 days, after which point the full depth of
the nerve could no longer be observed or imaged. This demonstrates that regeneration
studies can be performed using the spinal motor nerves of the trunk in midlarval
zebrafish until 19 dpf.
Repeated nerve lesioning in vivo
Another useful experimental paradigm enabled by the ability to image longer into the
midlarval stages is a repeated lesioning model. The idea of conditioning lesions has
been studied extensively in DRG neurons, which contain both CNS and PNS projecting
axons. It has been found that if the PNS projection is first injured and allowed to recover,
then the CNS projection is subsequently injured, the CNS axon will then regrow much
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more robustly than typical CNS regeneration (103). This is thought to be caused by cell
body changes in transcription that occur after the PNS injury, thus priming the cell body
for regeneration and aiding in the regrowth of the CNS projection when it is subsequently
injured. Conditioning lesions have also been seen to promote growth after subsequent
lesions in the mouse rat peripheral nerves (104,105). Typically, a conditioning crush will
be performed several days before the test crush, after which increased regeneration is
observed.
It is currently unknown whether conditioning lesions may promote subsequent regrowth
of motor axons in the zebrafish. Furthermore, lesioning a nerve repeatedly may cause
extra stress to the system and provide a sensitized condition in which to assay
regeneration. In this case, if a particular gene has a milder contribution to axonal
regrowth, we may be unable to see an effect on regeneration in our standard single
transection assay but may see an effect in the repeated lesioning paradigm after
transecting the same nerve multiple times.
In order to determine whether motor nerves in larval zebrafish can regenerate in
response to multiple lesions, I transected nerves in 5 dpf larvae, allowed them to regrow
for 6 days, then transected the nerves again (Figure 2.6, A-D). I then assayed regrowth
in response to the second lesion (Figure 2.6, E-H). I altered the site of transection from
our standard single lesion assay, cutting more distally so that there would be sufficient
regrowth to lesion a second time. This did in fact lead to robust regrowth 5 days after the
first lesion, and again 4 days after the second lesion. Given that the animal grows quite
dramatically in overall size throughout the course of this experiment (5 dpf, ~4 mm long
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to 15 dpf, ~15 mm long), it is difficult to qualitatively compare the appearance of the
nerve regrowth and determine whether regeneration is improved after a conditioning
lesion. Experiments following up on this preliminary result should compare this regrowth
to control animals that receive a single lesion at 11 dpf, without the conditioning lesion at
5 dpf. These initial results demonstrate that larval zebrafish can survive, be imaged and
have nerves transected throughout a 10 day assay in which both a conditioning lesion
and test lesion are administered.
Taken together, these experiments demonstrate an expanded potential of the zebrafish
for assessing nerve regeneration in vivo, allowing us to examine later time points than
before, as well as visualize subcellular components in Schwann cells.
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Figure 3.1: Microtubule structure in Schwann cells in vivo. Schwann cell
cytoskeletal structure in zebrafish larvae. (A) Tg(sox10:EB3-GFP) line 4, uninjured motor
nerve of 2 dpf larvae; images taken every 5 seconds for 2 minutes and time projected
(B) Tg(sox10:EB3-GFP) line 8, uninjured motor nerve 5 dpf larvae; images taken every 5
seconds for 2 minutes and time projected (C) Tg(NBT:dsRed) labels axons in red,
injected CldnK:EB3-GFP labels microtubule plus ends in green, uninjured motor nerve of
5 dpf larvae; images taken every 10 mins for 5 hours and time projected. (D) Acetylated
tubulin (green, microtubules) and znp1 (red, motor axons) stains in fixed 5 dpf larvae).
(E-F) Tg(sox10:Gal4;UAS:EB3-GFP) in 5 dpf larvae, images taken every 10 seconds for
2 minutes and time projected; in uninjured motor nerve (E) and 10 minutes post
transection (F).
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Figure 3.2: Schematic of mounting and imaging early and mid-larval zebrafish. (A)
Placement of early (5 dpf) and midstage (14-19 dpf) larvae in glass bottom imaging
dishes. (B) Enlargement of 5 dpf larvae; red box indicates imaging region of the ventral
motor nerve in the midtrunk section, the standard nerve for transection in our
regeneration studies. (C) Enlargement of a ~14-19 dpf larvae; red box 1 indicates ventral
nerve imaging region in the midtrunk section, red box 2 indicates ventral motor nerve
imaging region in the tail section.

54

Figure 3.3: Midlarval imaging in 14 dpf zebrafish. Tg(Hb9:GFP) labeling ventral motor
nerves. (A-B) Motor nerve in mid-trunk section before (A) and immediately after (B) laser
transection. (C-D) Motor nerve in tail section before (C) and immediately after (D) laser
transection. Motor nerves can be imaged and transected successfully in both areas.
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Figure 3.4: Midlarval imaging in 16 dpf zebrafish. Tg(Hb9:GFP) labeling ventral motor
nerves. (A-B) Motor nerve in mid-trunk section before (A) and immediately after (B) laser
transection. (C-D) Motor nerve in tail section before (C) and immediately after (D) laser
transection. Motor nerves can be imaged and transected successfully in both areas.
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Figure 3.5: Midlarval imaging in 19 dpf zebrafish. Tg(Hb9:GFP) labeling ventral motor
nerves. (A-B) Motor nerve in mid-trunk section before (A) and immediately after (B) laser
transection. (C-D) Motor nerve in tail section before (C) and immediately after (D) laser
transection. Motor nerves can be imaged and transected successfully in both areas.
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Figure 3.6 Repeated nerve lesioning in zebrafish larvae. Wild type larvae, motor
axons labeled with Tg(mnx1:GFP). (A) Pre-lesion motor nerve at 5 dpf, red box shows
site of transection. (B) Motor nerve at 5 dpf, 6 hours after first lesion. (C) Motor nerve at
8 dpf, 72 hours after first lesion. (D) Motor nerve at 11 dpf, 120 hours after first lesion;
red box shows site of second transection. (E) Motor nerve at 11 dpf, 0 hours after
second lesion. (F) Motor nerve at 11 dpf, 6 hours after second lesion. (G) Motor nerve at
13 dpf, 48 hours after second lesion. (H) Motor nerve at 15 dpf, 96 hours after second
lesion.

59

CHAPTER 5: MATERIALS AND METHODS
Ethics statement
All experiments were conducted according to an Animal Protocol fully approved by the
University of Pennsylvania Institutional Animal Care and Use Committee (IACUC) on
January 24, 2014, protocol number 803446. Veterinary care is under the supervision of
the University Laboratory Animal Resources (ULAR) of the University of Pennsylvania.
Zebrafish genetics and transgenes
All transgenic lines were maintained in the Tübigen or Tupfel long fin genetic
background and raised as previously described(106). Transgenic lines used are listed in
Table 5.1. Mutant lines used are listed in Table 5.2. Genotyping primers are listed in
Table 5.3.
Table 5.1: Transgenic lines.
Transgenic Lines

Tg(mnx1:GFP) ml2

Population labeled

Spinal motor neurons

Source

(107)

Tg(sox10(7.2):mRFP)vu234 Schwann cell membranes

(12)

Tg(UAS:lifeact-GFP-v2a-

Microtubule plus ends

Bremer et. al., in

EB3-RFP)

(red) and actin (green)

preparation
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Tg(sox10:EB3-GFP) line 4

Microtubule plus ends

generated

Tg(sox10:EB3-GFP) line 8

Microtubule plus ends

generated

Tg(Xla.Tubb:dsRed)

Pan-neuronal

(108)

Table 5.2: Mutant lines.
Mutant

dync1h1hi3684Tg

Mutation

Viral intronic insertion,

Source

(109)

presumed null from
nonsense-mediated decay

gpr126stl47

Indel causing frameshift

(110)

and early truncation

kif5Aasa7168

Point mutation in essential
splice site donor
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(111)

Table 5.3: Genotyping primers.

Mutant

Genotyping primers

dync1h1hi3684Tg F1: 5’-AAACCTACAGGTGGGGTCTTTC-3’

Reference

(109)

F2: 5’-CATGAACGTGGCGCTGGTAC-3’
R: 5’-GFTACAACTACGAGCAAGTCAACC-3’

gpr126stl47

F: 5’-GTCTTTGTCTCTGTCGATGC-3’

(110)

R: 5’:-GCTTGTAACTGATATGGAAGCC-3’

kif5Aasa7168

F: 5’-TGGAGAAACGTCTTCGTTCTACG-3’

(111)

R1: 5’-GTGTGTGAATGTGAATGCAGTGCACAGTGT-3’
R2: 5’-GTGTGTGAATGTGAATGCAGTGCACCAGCGT-3’

Nerve transection and live imaging
Nerve transection and live imaging were performed as previously described (51,52).
Axon growth extent quantification
Axon growth extent quantification was performed as previously described (52).
Transected nerves in which axons failed to regrow or did not extend through the entire
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length of the ventral myotome are categorized as “no/weak regeneration.” Nerves with at
least one fascicle that extended through the entire length of the ventral myotome are
categorized as “moderate regeneration.” Finally, nerves with two or more fascicles
extending through the entire length of the ventral myotome are categorized as “strong
regeneration.”
Axon extension and retraction quantification
Axons were imaged every 15 minutes from ~7 to ~16 hpt. Extensions and retractions
were defined as growth or retraction of >1 μm between timelapse frames and number of
extension and retraction events was counted. Continued movements of the same
direction in a subsequent frame were not counted as new events. Measurements were
performed on each visibly distinct axon in a nerve.
Growth cone displacement quantification
Axons imaged at ~16 hpt were measured by drawing a line from the spinal cord exit
point to the growth cone. Measurements were performed on each visibly distinct axon in
a nerve.
Schwann cell width quantification
Axons and Schwann cells were imaged before transection and every 15 minutes from ~1
to ~5 hpt. Schwann cell width was measured at the widest point in pre- and posttransection images. Using ImageJ, a line was drawn from one edge of the Schwann cell
membrane to the other in an orientation perpendicular to the motor nerve and was
measured in microns.
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Cell transplantation for chimera analysis
Cell transplantations were performed as previously described (32). Wild type cells were
transplanted into dync1h1-/- embryos in areas known to develop into motor neurons.
Larvae were screened at 5 dpf to identify nerves that contained transplanted motor
neurons and no other transplanted cell types along the path of the ventral motor nerve.
Transection, imaging, and quantification of growth cone displacement in identified
nerves were performed as described above.
Image processing
Image stacks were compressed into maximum intensity projections (MIPs) in Slidebook
6 then processed using ImageJ and Photoshop to normalize brightness and contrast.
Statistical analysis
Fisher’s exact and Student’s t tests were performed on all applicable datasets.
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CHAPTER 6: DISCUSSION
Molecular motors Kinesin-1 and Dynein are required for nerve regeneration in vivo
Microtubule-associated motors are critical for cellular maintenance, transporting
important cargos throughout a cell and also helping to modulate the dynamics of the
microtubules that they travel along. Previous studies have demonstrated a role for both
the anterograde motor kinesin-1 and the retrograde motor dynein in establishing
microtubule organization in developing axons. Additionally, many previous studies have
found that dynein is critical in transporting signaling complexes from the axon to the cell
body after injury. While this role for dynein in axonal regrowth has previously been
described, kinesin-1 and dynein have many cellular cargos and functions, raising the
possibility that these motors may be involved in nerve regeneration in multiple
capacities. Furthermore, studies of the dynein-dependent retrograde injury signal have
focused exclusively on the requirement for dynein in the axon. While neurons are known
to be particularly dependent on active transport for cellular maintenance due to their
length and highly polarized morphology, kinesin-1 and dynein are also critical in many
other cell types. As such, we sought to evaluate the role of kinesin-1 and dynein in a
multicellular context, using live-imaging in the zebrafish larvae to assess nerve
regeneration in a live, whole organism. We took advantage of homozygous zebrafish
mutants for the kif5aa and dync1h1 genes, since their motor nerves developed normally
due to maternal contribution. By transecting these nerves and imaging the regeneration
48 hours later, we showed for the first time a requirement for both kinesin-1 and dynein
in peripheral nerve regeneration in vivo.
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Dynein stabilizes axonal extensions during regeneration
Nerve injury induces a local signaling cascade that leads to the production of axon
intrinsic signals at the lesion site (112). There is overwhelming evidence that dynein is
critical to transport these injury signals from the lesion site to the cell body where they
initiate a neuronal injury response (113-115). We find that in presumptive dynein null
mutants, injured neurons robustly respond to the injury and within ~8-10 hours,
regenerating axons sprout from the proximal stump, indistinguishable from what we
observe in wild type animals. This raises the question whether axonal sprouting can
occur independently of dynein-dependent injury dependent signals, or whether in our
zebrafish model dynein-mediated retrograde transport is less important to mount an
injury response. One clear difference between rodent models and our model is the
distance between the injury site and the neuronal cell bodies. In rodent sciatic nerve
models lesions are introduced millimeters away from neuronal cell bodies (115), while in
larval zebrafish – due to the smaller animal size – lesions are generated about 10-50 μm
away from neuronal cell bodies (51) Thus, it is conceivable that due to the almost 100fold reduction in distance between lesion site and cell body, injury signal propagation
from the lesion site to the cell body is less dependent on dynein function. Although it
remains unclear how injury signal propagation can occur independent of dynein, this
provided us with the unique opportunity to examine dynein’s role in peripheral nerve
regeneration beyond its role in injury signal transport.
Endpoint analyses at 48 hpt uncovered a clear role for dynein in peripheral nerve
regeneration, with clear effects on both axonal regrowth and Schwann cell injury
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response (Figures 2.1 and 2.3). Using live-imaging to visualize the early stages of the
regeneration process, we found that dynein promotes the stabilization and growth of
long-range axonal projections, providing compelling evidence that apart from its welldocumented role in retrograde injury signal transport, dynein also plays a critical role in
sustaining axonal regrowth.
Dynein is required for Schwann cell remodeling after injury
In addition to the axonal regrowth defects observed in dynein mutants, simultaneously
visualizing the cellular behavior of both axons and Schwann cells revealed that loss of
dynein also prevented injury-induced Schwann cell remodeling. The transition of
Schwann cells from their fully differentiated state to a repair cell state is a welldocumented and integral aspect of peripheral nerve regeneration (95,116), accompanied
by dramatic morphological changes to the Schwann cell, as the cell breaks down its
myelin and extends its membrane to engulf axonal debris (117,118). Dynein regulates
several steps of membrane trafficking, including ER to Golgi transport, as well as
endosomal trafficking (119), so it is conceivable that dynein plays a direct, cellautonomous role in this process. Alternatively, the inability of Schwann cells to initiate
the remodeling process might be a consequence of strongly reduced axonal regrowth,
and future experiments will be required to test a possible Schwann cell-specific role for
dynein in the remodeling process. Of these two possibilities, however, it seems most
likely that dynein is playing a role specifically in the Schwann cell to promote remodeling
after injury. This is due to the timing of Schwann cell remodeling, which occurs at the
time of axonal fragmentation, hours before axonal regrowth begins. It is, however,
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possible that axon-Schwann cell communication before injury is critical to prime
Schwann cells to respond to injury, and this communication may be disrupted by the
absence of dynein and a potential impairment in signaling endosome transport, etc.
The absence of Schwann cell remodeling in dynein mutants also reveals novel insights
into the mechanism of Schwann cell injury response. It has previously been thought that
the morphological changes occurring in Schwann cells after injury result simply from the
loss of axonal tension as the distal axons fragment. However, we observe in dynein
mutants that even as distal axons fragment following injury, the Schwann cells do not
respond with characteristic morphological changes. This indicates that mechanical
forces alone are insufficient to induce the morphology changes observed in Schwann
cells after injury, and suggests that molecular and genetic mechanism drive this repair
cell transition both transcriptionally and morphologically.
This raises another interesting question regarding the relationship between Schwann cell
differentiation state and morphology changes after injury – does a change in Schwann
cell morphology after injury necessarily indicate that the transcriptionally regulated repair
cell transition has occurred, and vice versa? One way to address this question is to
assess the transcriptional state of dynein mutant Schwann cells after injury. While we
know that dynein mutant Schwann cells do not respond morphologically to injury, it is
possible that the appropriate transcriptional response towards the repair cell state still
occurs. The repair cell state is characterized by both dedifferentiation and activation
processes. Difficulties arise when trying to assess the repair cell transition
transcriptionally in dynein mutants, however, as these mutants also have defects that
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prevent full differentiation during development. As a result, many of the markers of the
repair cell transition are developmental marker that become re-expressed during the
transition to the repair cell state, such as Sox2 (120). Unfortunately, these markers never
actually become downregulated in the 5 dpf dynein mutant Schwann cells as the animal
matures. Thus, it will be critical to use transcriptional markers that are unique to the
repair cell state and are not simply developmental markers that are re-expressed after
injury, but rather distinct markers of Schwann cell activation after injury. One candidate
marker is c-Jun and its downstream targets, which are expressed at low levels in
Schwann cells developmentally but become highly expressed after injury (95,116).
In addition to further characterizing the repair cell transition by assessing transcriptional
changes that occur in Schwann cells after injury, it will also be useful to examine
cytoskeletal changes that occur after injury in both wild type and mutant animals. Using
the tools and techniques developed in Chapter 3, we can first assess the cytoskeletal
changes that drive Schwann cell remodeling in wild type animals. We can subsequently
assess the cytoskeleton in dynein mutant Schwann cells and determine whether any
cytoskeletal changes are initiated after injury, though the gross morphology does not
change appreciably. Together, these experiments will help determine to what extent the
cytoskeletal and morphological changes in Schwann cells after injury dictate the
transition to the repair cell state.
Neuronal dynein is sufficient to promote axonal regrowth after injury
Given that dynein mutants exhibit defects in axonal regrowth and Schwann cell
morphology, we performed chimeric analysis experiments to determine in which cell type
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dynein is required to promote nerve regeneration in vivo. These experiments revealed
that dynein function in injured neurons is sufficient to sustain axonal regeneration.
Importantly in our chimera experiments, of the roughly 60 axons contributing to an
individual motor nerve (121), on average only 1-3 transplanted wild type axons were
present. This low level of chimerism was critical to evaluate regrowth capacity of
individual wild type axons. This also revealed that the presence of individual wild type
axonal regrowth facilitated regrowth of individual, neighboring dynein deficient axons
(Figure 2.4, G-I). At the same time, the low level of chimerism precluded us from asking
whether neuronal dynein restored all aspects of peripheral nerve regeneration, including
injury-induced Schwann cell remodeling. Thus, while neuronal dynein plays a critical role
in sustaining axonal regrowth, we cannot exclude the possibility that dynein function in
Schwann cells also contributes to peripheral nerve regeneration.
Dynein promotes axonal regeneration by modulating microtubule dynamics
Cytoskeletal dynamics are critical to growth cone formation (122), axonal outgrowth
during development (123), and axonal regeneration (124). Previous studies have
revealed that microtubule stabilization promotes axonal regrowth after injury both in vitro
and in vivo (125-127). Interestingly, studies of C. elegans dynein heavy chain mutants
recently revealed that dynein acts locally in dendrites to stabilize microtubules (74). This
raised the possibility that dynein may also act locally in regenerating axons to stabilize
microtubules. We assessed cytoskeletal dynamics during regeneration using a
transgene that allowed us to visualize actin and microtubules simultaneously in live,
regenerating axons. This revealed that while actin dynamics were grossly unaffected in
dynein mutant axons, microtubules often appeared unstable and disordered, with some
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axons exhibiting looping microtubule configurations reminiscent of those seen in the
dendrites of C. elegans dynein heavy chain mutants (74). Thus, our results provide
compelling evidence that besides its well-documented role in retrograde transport,
dynein also promotes microtubule stability critical for growth cone advancement (128),
providing a potential mechanism for the rapid and sustained extension observed during
wild type axonal regrowth, and deficient in dynein mutants (Figure 2.6).
Dynein is also known to play a role in microtubule sliding (129), providing an alternative
mechanism through which dynein may modulate axonal microtubule dynamics during
regeneration. This may be a direct effect of dynein specifically interacting with
microtubules, as it has previously been shown that dynein slides microtubules in a
polarity-sorting manner during axon outgrowth. It is conceivable that dynein has this
same role during axonal regrowth after injury and that in the absence of dynein, the
polarity of microtubules in the axon is not established properly and eventually leads to
retraction of the axonal extension. This idea is consistent with the axonal extension
phenotype we observe in the dynein mutants, in which axonal extension proceeds for a
short distance before becoming destabilized and retracting.
Another possibility is that dynein may affect microtubule sliding indirectly via modulation
of kinesin-1, as these motors have been shown to transport each other directly (130).
Some studies in culture have shown that severe disruption of the anterograde motor
kinesin-1 can disrupt dynein-dependent transport, and vice versa. Further studies will be
required to determine whether dynein’s role in promoting axonal outgrowth specifically
affects microtubule sliding, and whether this effect is through a direct microtubule
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interaction or the modulation and transport of the anterograde motor, kinesin-1, which
has previously been found to power microtubule sliding during axonal outgrowth.
One remaining question regarding the role of dynein in modulating microtubule dynamics
after injury is whether dynein is a direct effector of microtubule dynamics, or whether
microtubule dynamics are simply a downstream effector of the retrograde injury signals
activated after injury. As discussed previously, we have not yet been able to determine
whether critical retrograde injury signals arrive at the cell body in the absence of dynein.
While the scale of the injury model in the zebrafish suggests that activated retrograde
injury signals can likely reach the cell body without active transport by dynein, it is still
possible that critical signals, such as p-JNK, are disrupted in the dynein mutant. It has
previously been shown that microtubules are downstream effectors of JNK signaling to
promote neurite outgrowth (131,132). In order to determine whether dynein is directly
affecting microtubule dynamics, it will be important to determine whether critical
retrograde injury signals such as p-ERK and p-JNK are detected in the cell bodies of
dynein mutant motor neurons after injury. Experiments are underway to visualize p-JNK
and p-ERK via antibody staining, and I have also obtained a construct for fluorescently
tagged p-JNK that can be used to visualize p-JNK in motor neurons after injury (133).
Experiments to test the direct interaction between dynein and microtubules in the
regrowing axon will be challenging, as dynein interacts with microtubules in its
microtubule binding domain for all cargo transport functions, as well as microtubule
sliding. An interesting experiment to further probe dynein’s role in modulating
microtubule dynamics during axonal regrowth is to use taxol to stabilize microtubules in
dynein mutant larvae. If the critical role for dynein in promoting axonal regrowth is in fact
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modulation of microtubule dynamics, we would expect that stabilization of microtubules
by taxol could rescue the axonal regrowth defects observed in dynein mutant nerves.
If it is confirmed that dynein is directly affecting microtubule dynamics in the regrowing
axon after injury, the nature of its interaction with microtubules should be examined. One
possibility is that dynein impacts microtubule stability, while another is that dynein is
critical for establishing appropriate microtubule polarity during axon outgrowth, as in
development. To distinguish between these functions, microtubule polarity should be
examined in regrowing axons. If dynein is indeed acting to slide microtubules in a
polarity-dependent manner, we would expect to see disrupted microtubule polarity in the
regrowing axons of dynein mutants. These experiments will help determine the specific
nature of dynein’s role in modulating axonal microtubule dynamins after injury.
Dynein in cytoskeletal maintenance: insight for human disease
Multiple mutations in the dynein heavy chain, DYNC1H1, have been found to cause
neurodegenerative conditions in human patients, indicating a critical role for the motor
dynein in neuronal homeostasis and maintenance. First, a dominant point mutation in
the homodimerization domain of DYNC1H1 was found to cause axonal Charcot-MarieTooth disease in a large family pedigree (44). Additionally, two dominant mutations in
the tail domain of DYNC1H1 have been found to cause spinal muscular atrophy (SMA)
(43), and biochemical analysis revealed that these mutations disrupted complex stability
and function.
Thus far, insights into the disease mechanism of these human mutations have come
from biochemical analysis in vitro as well as endpoint analysis of mouse mutants. The
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heterozygous dync1h1 mutants may provide another unique entry point into studying the
role of dynein in neuronal maintenance in vivo. The zebrafish dync1h1hi3684 mutation is
an intronic viral insertion in the motor domain of the dynein heavy chain, which is
expected to disrupt function and stability of the dynein complex (77). These
heterozygous dynein mutants are fully viable into adulthood, however our preliminary
results have revealed that cytoskeletal organization of the axon is severely disrupted in
these mutants (Figures 2.7, 2.8). This cytoskeletal disruption suggests a potential
mechanism for the axonal degeneration observed as a result DYNC1H1 mutations in
humans.
Interestingly, there are no obvious defects in the motor function of the heterozygous
dynein mutant zebrafish, despite their disrupted cytoskeletal structure. One possibility is
that these cytoskeletal defects do not disrupt axonal function, however this seems
unlikely since relatively minor mutations in cytoskeletal proteins can lead to severe
axonal degeneration in human and mouse mutants (Table 1.1). Another possibility is that
these adult heterozygotes have motor defects that are imperceptible without a closer
method of study. To determine whether dync1h1 heterozygotes have any functional
motor deficits, we can examine the startle response at larval, juvenile, and adult stages
as previously described by and developed in our lab. This will reveal whether there is
any developmental deficit in these animals, and additionally determine whether motor
function degenerates over time.
To complement these studies, we can also perform electron microscopy on motor
nerves at each of these stages and quantify the number of axons in a given nerve. This

74

should be another indication of whether axonal degeneration is occurring in these
animals, as we would expect the number of axons per nerve to decrease over time as a
result of degeneration. As mentioned previously, we can also examine cytoskeletal
structure in the axons at each of these stages to determine whether the cytoskeleton is
disrupted during development or degenerates over time, and additionally correlate this to
any functional deficits or axonal loss that is observed.
To further assess the cytoskeletal structure in axons of dynein heterozygotes, we can
use the fluorescently tagged cytoskeleton line described in Chapter 2 (Figure 2.6;
Tg(mnx1:Gal4) x Tg(UAS:EB3-RFP-lifeact-GFP)) combined with the midlarval imaging
techniques described in Chapter 3. This will allow us to monitor the axonal cytoskeleton
from the time of axon outgrowth in development through the midlarval stages, and
should reveal whether the axonal cytoskeleton in dynein heterozygotes is established
correctly in development, and also whether it degenerates over time. These experiments
may provide new insights into the disease mechanism of degenerative diseases caused
by dynein mutations, and may reveal that in addition to directing transport, dynein helps
establish and/or maintain cytoskeletal structure in axons.
Dynein promotes axonal degeneration after injury
While studies in human and mouse have revealed a role for dynein in neuronal
maintenance at homeostasis, our experiments revealed an additional role for dynein in
the active process of Wallerian degeneration. Following nerve injury, we observed that
dynein mutant axons in the distal stump show an extended lag phase prior to axonal
fragmentation, indicating that dynein promotes Wallerian degeneration. Previous studies
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of axonal degeneration have found that upon nerve crush or transection, cargos
traveling retrogradely in the axon accumulate just distal to the site of injury as they can
no longer pass into the proximal axon segment. This phenomenon has often been
considered from the perspective of the cell body and proximal axon – that this
accumulation of cargos distally subsequently results in a lack of these cargos and
signals in the proximal nerve segment. Given that dynein affects the timing of axonal
fragmentation in the distal stump, it seems it may have a more active function in the
distal part of the nerve than previously thought.
One possibility is that cargo accumulation at the end of the distal nerve segment
somehow induces Wallerian degeneration. In the absence of dynein, we would expect
that cargo distribution is already disrupted and the change after injury would be less
pronounced. Given that Wallerian degeneration is a process initiated by active death
signals in the axon, it is also possible that dynein-mediated transport is required for the
distribution of relevant signals through the axon to coordinate axonal fragmentation.
Notably, when axonal fragmentation occurs, the entire length of the axon fragments at
the same time, suggesting tight temporal and spatial regulation of the fragmentation
process. Given dynein’s key role in controlling the spatial distribution of critical cellular
cargos, it is tempting to speculate that dynein’s role in promoting Wallerian degeneration
is related to this function.
One specific cargo of dynein that may be particularly critical for Wallerian degeneration
is the autophagosome. In neurons, autophagosomes initiate distally and enclose cellular
contents to be degraded. They then complex with dynein and travel retrogradely where
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they fuse with lysosomes and degrade their contents. The process of autophagy is likely
disrupted in that axons of dynein mutants, and this could be one explanation for the
disrupted axonal fragmentation that is observed. It is conceivable that in addition to
engulfment by macrophages and Schwann cells, the axonal debris generated upon
fragmentation is also in part degraded by the neuron itself. This would process would
likely occur prior to fragmentation while the axons are still intact, and could represent
one functional benefit of the lag phase observed in Wallerian degeneration. Further
studies will be required to determine whether autophagosome distribution and function is
observed in dynein mutant axons. Additionally, it will be important to determine whether
specifically disrupting autophagy affects the timing of axonal fragmentation after injury.
The preliminary studies described here are the first demonstration that the molecular
motor dynein promotes the process of Wallerian degeneration following injury in vivo.
Follow up studies will reveal more about the specific mechanism by which dynein
controls the precise timing of axonal fragmentation.
Conclusions
The work in this thesis demonstrates novel roles for the motor proteins kinesin-1 and
dynein in peripheral nerve regeneration in vivo. It identifies additional mechanisms,
beyond the transport of retrograde injury signals, by which dynein promotes axonal
regrowth. It also provides preliminary evidence that dynein promotes cytoskeletal
maintenance in axons as well as degeneration after injury, and suggests potential
mechanisms of these roles. Taken together, these studies reveal previously unknown
functions of dynein in peripheral nerve de- and regeneration.
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